Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

1 030 evidences · page 3 / 42

Moderately (type A(+)) and severely (type A(-)) G6PD deficiency showed significant association with lower haemoglobin concentrations at baseline in African children with severe malaria.

Gabonpaludismepublié 2016Malaria journaleurope_pmcdocument de 7 observations

7 %In Dienga, southeastern Gabon, the prevalence of microscopic P. falciparum infection was 7% in 2003.

Gabonpaludismeobservé 2003publié 2016PloS oneeurope_pmcdocument de 9 observations

80,8 %At day 28, the PCR-unadjusted efficacy of amodiaquine-artesunate was 80.8%.

Gabonpaludismepublié 2011PLoS medicineeurope_pmcdocument de 15 observations

6,1 %Malaria and COVID-19 co-infections were diagnosed in 3 (6.1%) patients among febrile patients screened in Gabon from October 2021 to December 2021.

GabonCOVID-19 · paludismeobservé October 2021 to December 2021publié 2022Southern African journal of infectious diseaseseurope_pmcdocument de 4 observations

69,6 %Malaria infection prevalence was 69.6% among school-aged children in Gabon.

Gabonpaludismeobservé 2021publié 2024Tropical medicine and infectious diseaseeurope_pmcdocument de 8 observationsDOI 10.3390/tropicalmed10010011

45,9 %For low-level parasitemias, venous blood microscopy sensitivity dropped to 45.9%.

Gabonpaludismeobservé 2015–2016publié 2018The Journal of infectious diseaseseurope_pmcdocument de 8 observationsDOI 10.1093/infdis/jiy319

10,3 %The wild-type D1246 Pfmdr1 genotype prevalence was 10.3% in symptomatic infections and 100% in asymptomatic infections.

Gabonpaludismepublié 2021Infection and drug resistanceeurope_pmcdocument de 10 observationsDOI 10.2147/idr.s304361

4 %In an efficacy open-label clinical trial with a 28-day follow-up in 29 children under five with uncomplicated malaria, PCR-corrected, 1/26 (4%) had an early treatment failure, resulting in early trial discontinuation.

Gabonpaludismepublié 2011Malaria journaleurope_pmcdocument de 5 observationsDOI 10.1186/1475-2875-10-123

6,5 %Vaccine efficacy of GMZ2/alum was 6.5% against clinical malaria over 24 months in the intention-to-treat analysis.

Gabonpaludismepublié 2021VaccinePubMeddocument de 3 observations

0,45 adjusted_odds_ratioParity was associated with Plasmodium falciparum infection, with an adjusted odds ratio of 0.45 for multipara versus paucipara.

Gabonpaludismeobservé 2008–2011publié 2013Malaria JournalOpenAlexdocument de 6 observationsDOI 10.1186/1475-2875-12-412

45,4 %The K1/msp-1 allelic family was predominant in urban areas (45.4%) in the Republic of Congo during a cross-sectional survey conducted from March to September 2021.

Gabonpaludismeobservé March to September 2021publié 2023Pathogens (Basel, Switzerland)europe_pmcdocument de 8 observationsDOI 10.3390/pathogens12050742

85,3 %PCR-corrected adequate clinical and parasitological response (ACPR) in the per-protocol set was 85.3% for artesunate-pyronaridine-atovaquone-proguanil (APAP) at day 42.

Gabonpaludismepublié 2026The Lancet. Microbeeurope_pmcdocument de 21 observations

397 isolatesA total of 397 (72.4%) Plasmodium falciparum isolates were collected in rural areas in the Republic of Congo during a cross-sectional survey conducted from March to September 2021.

Gabonpaludismeobservé March to September 2021publié 2023Pathogens (Basel, Switzerland)europe_pmcdocument de 8 observationsDOI 10.3390/pathogens12050742

87,1 %Day 28 PCR-adjusted adequate clinical and parasitological response (ACPR) was 87.1% (27/31) with 400 mg ferroquine plus 1000 mg artefenomel.

Gabonpaludismepublié 2023Malaria journaleurope_pmcdocument de 13 observations

0,35 rhoThere were strong correlations between cortisol concentration and parasite load in Plasmodium falciparum-infected primigravidae women (rho between 0.35 and 0.45 with P < 0.01).

Gabonpaludismepublié 2005Microbes and infectioneurope_pmcdocument de 7 observations

92 %For low-level parasitemias, capillary and venous blood microscopy specificities were 92%.

Gabonpaludismeobservé 2015–2016publié 2018The Journal of infectious diseaseseurope_pmcdocument de 8 observationsDOI 10.1093/infdis/jiy319

4 casesIn four neonatal malaria cases, the Plasmodium species was not reported.

Gabonpaludismepublié 2025BMC infectious diseasesPubMeddocument de 17 observations

79 %In 1995/96, 79% of the isolates carried the same microsatellite alleles in a chromosomal fragment spanning 39 kb surrounding the pfcrt locus.

Gabonpaludismeobservé 1995/96publié 2011Malaria journaleurope_pmcdocument de 4 observationsDOI 10.1186/1475-2875-10-304

53,4 %La prévalence de Plasmodium spp. chez les enfants de 5 à 9 ans était de 53,4 %.

GabonpaludismeHAL · Unilimdocument de 81 observations

1 373 parasites/μLLa densité médiane de parasites Plasmodium falciparum était de 1373 parasites/μL chez les enfants porteurs de l’allèle APOE Ɛ4, contre 631 parasites/μL chez les enfants non-porteurs.

GabonpaludismeHAL · Unilimdocument de 81 observations

54,5 %The FC27/msp-2 allelic family was predominant in urban areas (54.5%) in the Republic of Congo during a cross-sectional survey conducted from March to September 2021.

Gabonpaludismeobservé March to September 2021publié 2023Pathogens (Basel, Switzerland)europe_pmcdocument de 8 observationsDOI 10.3390/pathogens12050742

0,48 relative_riskThe relative risk of overall malaria infection in the intervention group compared to the control group was 0.48.

Gabonpaludismepublié 2024The Lancet. Infectious diseasesPubMeddocument de 6 observations

38 %FCR-3 strains (F-segment) were found in 19 out of 50 symptomatic children, representing 38%.

Gabonpaludismepublié 2006Clinical medicine & researcheurope_pmcdocument de 7 observationsDOI 10.3121/cmr.4.1.7

33 patientsOf 168 patients, 33 (20%) developed critical disease.

Gabonpaludismeobservé 2013-2023publié 2025Journal of travel medicinePubMeddocument de 5 observations

70,6 %Anemia was the most common feature of severe malaria, present in 70.6% of cases (n = 12/17).

Gabonpaludismepublié 2016Parasite (Paris, France)europe_pmcdocument de 9 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.